Literature DB >> 11286672

The role of psychiatric disorders in fibromyalgia.

J McBeth1, A J Silman.   

Abstract

The cardinal features of fibromyalgia are chronic widespread pain in the presence of widespread tenderness as measured by multiple tender points. Despite extensive investigations, the etiology of this syndrome remains unclear. Increased rates of psychiatric disorders, particularly depressive, anxiety, and somatoform disorders, are apparent in clinic populations. Epidemiologic evidence suggests that this is also true for community subjects. Depression, generalized psychological distress, and other psychological factors have been shown to be associated with the onset and persistence of fibromyalgia symptoms. However, the bodily processes through which such factors may lead to the onset of fibromyalgia are unclear. Recent investigations have demonstrated altered stress system responsiveness, most notably the hypothalamic-pituitary-adrenal stress axis, in patients with fibromyalgia. These findings, and one promising avenue for investigating the interaction between psychological and biological factors in the onset of chronic pain syndromes including fibromyalgia, are discussed.

Entities:  

Mesh:

Year:  2001        PMID: 11286672     DOI: 10.1007/s11926-001-0011-8

Source DB:  PubMed          Journal:  Curr Rheumatol Rep        ISSN: 1523-3774            Impact factor:   4.592


  71 in total

1.  Fibrositis: A Biographical Study of Fifty Civilian and Military Cases, from the Rheumatic Unit, St. Stephen's Hospital (London County Council), and a Military Hospital.

Authors:  P Ellman; O A Savage; E Wittkower; T F Rodger
Journal:  Ann Rheum Dis       Date:  1942-05       Impact factor: 19.103

2.  Undetected fibrositis in primary care practice.

Authors:  A Hartz; E Kirchdoerfer
Journal:  J Fam Pract       Date:  1987-10       Impact factor: 0.493

3.  The London Fibromyalgia Epidemiology Study: the prevalence of fibromyalgia syndrome in London, Ontario.

Authors:  K P White; M Speechley; M Harth; T Ostbye
Journal:  J Rheumatol       Date:  1999-07       Impact factor: 4.666

4.  Early sexual abuse and lifetime psychopathology: a co-twin-control study.

Authors:  S Dinwiddie; A C Heath; M P Dunne; K K Bucholz; P A Madden; W S Slutske; L J Bierut; D B Statham; N G Martin
Journal:  Psychol Med       Date:  2000-01       Impact factor: 7.723

5.  Evidence of disordered symptom appraisal in fibromyalgia: increased rates of reported comorbidity and comorbidity severity.

Authors:  F Wolfe; D J Hawley
Journal:  Clin Exp Rheumatol       Date:  1999 May-Jun       Impact factor: 4.473

6.  Somatized depression as a subgroup of fibromyalgia syndrome.

Authors:  A Meyer-Lindenberg; B Gallhofer
Journal:  Z Rheumatol       Date:  1998       Impact factor: 1.372

Review 7.  A review of the long-term effects of child sexual abuse.

Authors:  J H Beitchman; K J Zucker; J E Hood; G A daCosta; D Akman; E Cassavia
Journal:  Child Abuse Negl       Date:  1992

8.  The role of anxiety and depression in fatigue and patterns of pain among subgroups of fibromyalgia patients.

Authors:  N Kurtze; K T Gundersen; S Svebak
Journal:  Br J Med Psychol       Date:  1998-06

9.  Medical and psychiatric determinants of outpatient medical utilization.

Authors:  A J Barsky; G Wyshak; G L Klerman
Journal:  Med Care       Date:  1986-06       Impact factor: 2.983

10.  Sexual and physical abuse in women with fibromyalgia: association with outpatient health care utilization and pain medication usage.

Authors:  R W Alexander; L A Bradley; G S Alarcón; M Triana-Alexander; L A Aaron; K R Alberts; M Y Martin; K E Stewart
Journal:  Arthritis Care Res       Date:  1998-04
View more
  10 in total

Review 1.  Mindfulness Meditation for Fibromyalgia: Mechanistic and Clinical Considerations.

Authors:  Adrienne L Adler-Neal; Fadel Zeidan
Journal:  Curr Rheumatol Rep       Date:  2017-09       Impact factor: 4.592

Review 2.  Characteristics of women who have had cosmetic breast implants that could be associated with increased suicide risk: a systematic review, proposing a suicide prevention model.

Authors:  Nikolaos Manoloudakis; Georgios Labiris; Nefeli Karakitsou; Jong B Kim; Yezen Sheena; Dimitrios Niakas
Journal:  Arch Plast Surg       Date:  2015-03-16

Review 3.  Management of fibromyalgia.

Authors:  Ashwin A Patkar; Louai Bilal; Prakash S Masand
Journal:  Curr Psychiatry Rep       Date:  2003-07       Impact factor: 5.285

Review 4.  Sexual dysfunction in patients with fibromyalgia.

Authors:  Cristóbal Orellana; Jordi Gratacós; Carlos Galisteo; Marta Larrosa
Journal:  Curr Rheumatol Rep       Date:  2009-12       Impact factor: 4.592

5.  [Altered function of the hypothalamic-pituitary-adrenal axis in patients with acute, chronic and episodic pain].

Authors:  M Strittmatter; O Bianchi; D Ostertag; M Grauer; C Paulus; C Fischer; S Meyer
Journal:  Schmerz       Date:  2005-04       Impact factor: 1.107

6.  Fibromyalgia syndrome: etiology, pathogenesis, diagnosis, and treatment.

Authors:  Enrico Bellato; Eleonora Marini; Filippo Castoldi; Nicola Barbasetti; Lorenzo Mattei; Davide Edoardo Bonasia; Davide Blonna
Journal:  Pain Res Treat       Date:  2012-11-04

7.  The Prevalence and Characteristics of Fibromyalgia in the 2012 National Health Interview Survey.

Authors:  Brian Walitt; Richard L Nahin; Robert S Katz; Martin J Bergman; Frederick Wolfe
Journal:  PLoS One       Date:  2015-09-17       Impact factor: 3.240

Review 8.  The Evolution of Fibromyalgia, Its Concepts, and Criteria.

Authors:  Frederick Wolfe; Johannes J Rasker
Journal:  Cureus       Date:  2021-11-29

9.  Fibromyalgia in women: association of inflammatory plasma proteins, muscle blood flow, and metabolism with body mass index and pain characteristics.

Authors:  Bijar Ghafouri; Emelie Edman; Marie Löf; Eva Lund; Olof Dahlqvist Leinhard; Peter Lundberg; Mikael Fredrik Forsgren; Björn Gerdle; Huan-Ji Dong
Journal:  Pain Rep       Date:  2022-10-04

10.  Sexual dysfunction, mood, anxiety, and personality disorders in female patients with fibromyalgia.

Authors:  Fatih Kayhan; Adem Küçük; Yılmaz Satan; Erdem İlgün; Şevket Arslan; Faik İlik
Journal:  Neuropsychiatr Dis Treat       Date:  2016-02-16       Impact factor: 2.570

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.